Michael Roughton
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.
Journal: Neuro-oncology practice
Published: December 29, 2025
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 11, 2025
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.
Journal: European journal of endocrinology
Published: April 11, 2022
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 20, 2021
Is Cardiomegaly an Indication of "Heart-Sparing Effect" in Small Fetuses?
Journal: Fetal diagnosis and therapy
Published: April 11, 2021
Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: January 15, 2020
Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study.
Journal: Pituitary
Published: August 24, 2019
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study.
Journal: Clinical endocrinology
Published: June 27, 2019
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
Journal: The lancet. Diabetes & endocrinology
Published: May 04, 2017
Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation.
Journal: Circulation. Cardiovascular interventions
Published: August 17, 2015
Systemic right ventricular fibrosis detected by cardiovascular magnetic resonance is associated with clinical outcome, mainly new-onset atrial arrhythmia, in patients after atrial redirection surgery for transposition of the great arteries.
Journal: Circulation. Cardiovascular imaging
Published: May 08, 2015
Last Updated: 09/26/2026